Business Description
Enveric Biosciences Inc
NAICS : 541714
SIC : 2834
ISIN : US02362F1049
Description
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. The company's lead program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. Enveric is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, being studied as a treatment of psychiatric disorders.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.83 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 46.7 | |||||
| 3-Year EPS without NRI Growth Rate | 47.6 | |||||
| 3-Year FCF Growth Rate | 42.4 | |||||
| 3-Year Book Growth Rate | -65.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 40.27 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 14.91 | |||||
| 9-Day RSI | 19.59 | |||||
| 14-Day RSI | 26.67 | |||||
| 6-1 Month Momentum % | -38.89 | |||||
| 12-1 Month Momentum % | -65.45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.17 | |||||
| Quick Ratio | 5.17 | |||||
| Cash Ratio | 3.71 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -138.5 | |||||
| Shareholder Yield % | -144.37 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -243.59 | |||||
| ROA % | -160.99 | |||||
| ROIC % | -821.48 | |||||
| ROC (Joel Greenblatt) % | -1439.67 | |||||
| ROCE % | -264.22 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.74 | |||||
| Price-to-Tangible-Book | 0.76 | |||||
| EV-to-EBIT | 0.36 | |||||
| EV-to-EBITDA | 0.37 | |||||
| EV-to-FCF | 0.47 | |||||
| Price-to-Net-Current-Asset-Value | 0.83 | |||||
| Price-to-Net-Cash | 1.3 | |||||
| Earnings Yield (Greenblatt) % | 277.78 | |||||
| FCF Yield % | -252.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ENVB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Enveric Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.57 | ||
| Beta | 0.72 | ||
| Volatility % | 120.88 | ||
| 14-Day RSI | 26.67 | ||
| 14-Day ATR ($) | 0.041808 | ||
| 20-Day SMA ($) | 0.40646 | ||
| 12-1 Month Momentum % | -65.45 | ||
| 52-Week Range ($) | 0.3051 - 2.92 | ||
| Shares Outstanding (Mil) | 9.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Enveric Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Enveric Biosciences Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Enveric Biosciences Inc Frequently Asked Questions
What is Enveric Biosciences Inc(ENVB)'s stock price today?
The current price of ENVB is $0.33. The 52 week high of ENVB is $2.92 and 52 week low is $0.31.
When is next earnings date of Enveric Biosciences Inc(ENVB)?
The next earnings date of Enveric Biosciences Inc(ENVB) is 2025-03-26 Est..
Does Enveric Biosciences Inc(ENVB) pay dividends? If so, how much?
Enveric Biosciences Inc(ENVB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers